Organon & Co. (OGN)
(Delayed Data from NYSE)
$9.75 USD
+0.05 (0.52%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $9.64 -0.11 (-1.13%) 7:58 PM ET
2-Buy of 5 2
A Value F Growth C Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Organon & Co. has a PEG ratio of 0.94 compared to the Medical Services industry's PEG ratio of 1.52.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
OGN 9.75 +0.05(0.52%)
Will OGN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for OGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OGN
Insights Into Organon (OGN) Q2: Wall Street Projections for Key Metrics
Organon (OGN) Sees a More Significant Dip Than Broader Market: Some Facts to Know
OGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cencora (COR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Organon (OGN) Expected to Beat Earnings Estimates: Should You Buy?
Organon (OGN) Outperforms Broader Market: What You Need to Know
Other News for OGN
Organon & Co (OGN) to Announce Second Quarter 2025 Financial Results | OGN stock news
Organon To Report Second Quarter 2025 Results and Host Conference Call on August 5, 2025 | OGN ...
Organon & Co (OGN) Faces Securities Fraud Class Action Lawsuit | OGN stock news
OGN September 19th Options Begin Trading
XPH: Healthcare Dashboard For July